Drug discovery tools in this category use knowledge‑graph‑driven AI to surface and prioritise targets by connecting signals across biomedical literature, omics datasets, clinical data, and real‑world evidence. These AI solutions in healthcare typically encode entities such as genes, pathways, diseases, and drugs as a graph, then apply machine learning and reasoning to identify novel mechanisms, repositioning opportunities, and high‑value hypotheses before preclinical and clinical investment. Key evaluation angles include quality and provenance of underlying data sources, transparency and explainability of graph‑based inferences, integration with existing research platforms and decision workflows, and alignment with internal target assessment, IP, and regulatory frameworks.

Browse the AI tools below to identify the Knowledge‑Graph‑Driven Target Discovery platforms that best match your data, workflow, and governance requirements.

This category page is for informational purposes only and does not constitute regulatory, clinical, or investment advice; organisations should conduct their own technical, legal, and governance due diligence before selecting any AI solutions in healthcare.